BERNARD BOURRIE,PIERRE CASELLAS,SYLVIE COSNIER-PUCHEU,SAMIR JEGHAM,PIERRE PERREAUT
申请号：
MX2014011054
公开号：
MX2014011054A
申请日:
2013.03.13
申请国别(地区):
MX
年份:
2015
代理人:
摘要：
The present invention relates to combinations of N-[2-(2,1,3-benzothiadiazol-5- ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N-(1,1-dimethylethyl)-urea and cytarabine and their use for treating AML or CML.La presente invención se refiere a combinaciones de N-[2-(2, 1 ,3-benzotiadiazol-5-ilamino)-6-(2,6-diclorofenil)pirido[2,3-d]pir imidin-7-iI]-N-(1, 1-dimetiletil)-urea y citarabina, y a su uso para tratar la LMA o la LMC.
